SK Bioscience Co Ltd (302440) — Strategic Asset Allocation Index
SK Bioscience Co Ltd (302440) has a Strategic Asset Allocation Index of 16.7% as of September 2022. Strategic assets (PP&E of ₩285.90 Billion plus long-term investments of ₩-) total ₩285.90 Billion, measured against net assets of ₩1.71 Trillion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 302440 equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
SK Bioscience Co Ltd Strategic Asset Allocation Index (2020–2021)
This chart shows how SK Bioscience Co Ltd's Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2021. As of September 2022, the index stands at 16.7%, representing strategic assets of ₩285.90 Billion against net assets of ₩1.71 Trillion KRW. For live market cap and overall valuation, see 302440 stock market capitalisation.
Annual Strategic Asset Allocation Index for SK Bioscience Co Ltd (2020–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for SK Bioscience Co Ltd from 2020 to 2021, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of SK Bioscience Co Ltd for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 13.8% | ₩220.98 Billion | ₩220.98 Billion | ₩- | ₩1.60 Trillion | ▼ -58.0 pp |
| 2020 | 71.8% | ₩189.48 Billion | ₩189.48 Billion | ₩- | ₩263.79 Billion | — |